HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Carotinoid retinopathy. III. Reversibility].

Abstract
Twenty-five patients (erythropoietic protoporphyria 23, polymorphous light eruption 1, "cosmetics" 1) were re-examined 2-10 months after therapy with beta-carotene and canthaxanthine was discontinued. Dark adaptation and ERG parameters had normalized, whereas crystalline retinopathy and pigment epithelial defects showed no signs of reversibility.
AuthorsU Weber, G Goerz
JournalKlinische Monatsblätter für Augenheilkunde (Klin Monbl Augenheilkd) Vol. 188 Issue 1 Pg. 20-2 (Jan 1986) ISSN: 0023-2165 [Print] GERMANY, WEST
Vernacular TitleCarotinoid-Retinopathie. III. Reversibilität.
PMID3959472 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Drug Combinations
  • Porphyrins
  • Protoporphyrins
  • beta Carotene
  • Carotenoids
  • Canthaxanthin
  • phenoro
Topics
  • Canthaxanthin
  • Carotenoids (adverse effects, analogs & derivatives, therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Combinations (adverse effects, therapeutic use)
  • Electroretinography
  • Fluorescein Angiography
  • Follow-Up Studies
  • Humans
  • Photosensitivity Disorders (drug therapy)
  • Porphyrias (drug therapy)
  • Porphyrins (blood)
  • Protoporphyrins (blood)
  • Retinal Diseases (chemically induced)
  • Skin Diseases (drug therapy)
  • beta Carotene

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: